New leadership and recapitalization to accelerate commercialization of proprietary silicon nitride technologies in medical and high-growth markets
SALT LAKE CITY, Utah, June 12, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), the only FDA-registered producer of implantable silicon nitride and a global leader in advanced ceramics, today announced a renewed corporate vision and strategic plan to accelerate commercialization and unlock the full value of its intellectual property portfolio. This follows the company’s successful recapitalization in February 2025 and the restructure of its leadership team and Board of Directors.
Read more at globenewswire.com